Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Ruoshi Shi"'
Autor:
Ming-Sound Tsao, Nadeem Moghal, Geoffrey Liu, Benjamin Haibe-Kains, Nhu-An Pham, Laura Tamblyn, Yu-Hui Wang, Ming Li, Joshua C. Rosen, Arvind Singh Mer, Quan Li, Vibha Raghavan, Sebastiao N. Martins-Filho, Michael Cabanero, Hirotsugu Notsuda, Ni Liu, Christine Ng, Nikolina Radulovich, Ruoshi Shi
Supplementary Data Table S1, 3-4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad664809adbc53e2b5a1f2cb59afe6a8
https://doi.org/10.1158/1078-0432.22474499.v1
https://doi.org/10.1158/1078-0432.22474499.v1
Autor:
Ming-Sound Tsao, Nadeem Moghal, Geoffrey Liu, Benjamin Haibe-Kains, Nhu-An Pham, Laura Tamblyn, Yu-Hui Wang, Ming Li, Joshua C. Rosen, Arvind Singh Mer, Quan Li, Vibha Raghavan, Sebastiao N. Martins-Filho, Michael Cabanero, Hirotsugu Notsuda, Ni Liu, Christine Ng, Nikolina Radulovich, Ruoshi Shi
Purpose:Non–small cell lung cancer (NSCLC) is the most common cause of cancer-related deaths worldwide. There is an unmet need to develop novel clinically relevant models of NSCLC to accelerate identification of drug targets and our understanding o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::048c8862d3e9f390a18a9389b4defa6f
https://doi.org/10.1158/1078-0432.c.6528803
https://doi.org/10.1158/1078-0432.c.6528803
Autor:
Ming-Sound Tsao, Nadeem Moghal, Frances A. Shepherd, Nhu-An Pham, Michael Cabanero, Shirley Tam, Vibha Raghavan, Ming Li, Ruoshi Shi
Supplementary Table S1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bffaed610eef3dc0693f1e775440b69
https://doi.org/10.1158/1078-0432.22469942
https://doi.org/10.1158/1078-0432.22469942
Autor:
Ming-Sound Tsao, Nadeem Moghal, Frances A. Shepherd, Nhu-An Pham, Michael Cabanero, Shirley Tam, Vibha Raghavan, Ming Li, Ruoshi Shi
Supplementary Figure S1-7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3075595148a70acc4ce8f1f08e1f20f
https://doi.org/10.1158/1078-0432.22469945.v1
https://doi.org/10.1158/1078-0432.22469945.v1
Autor:
Ming-Sound Tsao, Nadeem Moghal, Geoffrey Liu, Benjamin Haibe-Kains, Nhu-An Pham, Laura Tamblyn, Yu-Hui Wang, Ming Li, Joshua C. Rosen, Arvind Singh Mer, Quan Li, Vibha Raghavan, Sebastiao N. Martins-Filho, Michael Cabanero, Hirotsugu Notsuda, Ni Liu, Christine Ng, Nikolina Radulovich, Ruoshi Shi
Supplementary Data Figure S1-5, Table S2, 5-7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f872d0d89cfa35e487960741dd208633
https://doi.org/10.1158/1078-0432.22474502.v1
https://doi.org/10.1158/1078-0432.22474502.v1
Publikováno v:
2022 41st Chinese Control Conference (CCC).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::37d10369d5b3234c1d5b81a5d27222e2
https://doi.org/10.23919/ccc55666.2022.9901530
https://doi.org/10.23919/ccc55666.2022.9901530
Autor:
Sebastiao N. Martins Filho, Deepti Ravi, Jessica Weiss, Nhu-An Pham, Adrian G. Sacher, Ruoshi Shi, Michael Cabanero, Olga Ludkovski, Nadeem Moghal, Ming Li, Aline Fusco Fares, Frances A. Shepherd, Kazuhiro Yasufuku, Ming-Sound Tsao, Quan Li, Natasha B. Leighl, Penelope A. Bradbury, Vibha Raghavan, Geoffrey Liu
Publikováno v:
Lung Cancer. 146:78-85
Background Anaplastic lymphoma kinase (ALK) targeted therapies have demonstrated remarkable efficacy in ALK-positive lung adenocarcinomas. However, patients inevitably develop resistance to such therapies. To investigate novel mechanisms of resistanc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6f685da631f292b11a5fc4c01656f1d
https://doi.org/10.1016/j.lungcan.2020.05.018
https://doi.org/10.1016/j.lungcan.2020.05.018
Publikováno v:
The North American Journal of Economics and Finance. 62:101781
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a40a85516ff43dac4ed39bffc6039826
https://doi.org/10.1016/j.najef.2022.101781
https://doi.org/10.1016/j.najef.2022.101781
Autor:
Céline Mascaux, Catherine A. O’Brien, Jessica Weiss, Nhu-An Pham, Geoffrey Liu, Aline Fusco Fares, Denis Tkachuk, Chantal Ho, Benjamin Haibe-Kains, Gangesh Beri, Elijah Tai, Anna Goldenberg, Ruoshi Shi, Arvind Singh Mer, David W. Cescon, Ming-Sound Tsao, Sheng Guo, Ladislav Rampášek, Shingo Sakashita, Janosch Ortmann, Erin L. Stewart, Xiaoqian Jiang, Christopher Eeles
Quantifying response to drug treatment in mouse models of human cancer is important for treatment development and assignment, and yet remains a challenging task. A preferred measure to quantify this response should take into account as much of the ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ee89a709fc50ab41775b3a188c61ebc
https://doi.org/10.1101/2020.09.08.287573
https://doi.org/10.1101/2020.09.08.287573
Autor:
Ruoshi Shi, Judy Mcconnell, Prodipto Pal, Alexandria Grindlay, Nhu-An Pham, Jessica Weiss, Ming Li, Quan Li, Penelope A. Bradbury, Natasha B. Leighl, Ming-Sound Tsao, Frances Allison, Frances A. Shepherd, Michael Cabanero, Adrian G. Sacher, Erin L. Stewart, Sebastiao N. Martins-Filho, Aline Fusco Fares, Nadeem Moghal, Geoffrey Liu, Devalben Patel, Kazuhiro Yasufuku
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 145
Objective Patient-derived xenografts (PDX) are useful preclinical models to study cancer biology and mechanisms of drug response/resistance, particularly in molecularly targetable tumors. However, PDX engraftment may not be stochastic. We investigate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82e30aaeabaf873d1ee7ef54f06b7990
https://pubmed.ncbi.nlm.nih.gov/32447118
https://pubmed.ncbi.nlm.nih.gov/32447118